Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
TerrAscend Corp ( (TSE:TSND) ) has provided an announcement.
TerrAscend Corp. announced the results of its annual general meeting, where shareholders approved the re-election of key directors and the re-appointment of MNP LLP as the company’s auditor. Additionally, a resolution was passed to modify the exercise prices of certain stock options. These decisions are expected to maintain stability in the company’s leadership and financial oversight, potentially impacting its strategic positioning in the cannabis industry.
The most recent analyst rating on (TSE:TSND) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on TerrAscend Corp stock, see the TSE:TSND Stock Forecast page.
Spark’s Take on TSE:TSND Stock
According to Spark, TipRanks’ AI Analyst, TSE:TSND is a Neutral.
TerrAscend Corp faces significant challenges, primarily due to weak financial performance and bearish technical indicators. While strategic acquisitions indicate potential for growth, the current financial and market conditions pose considerable risks to investors.
To see Spark’s full report on TSE:TSND stock, click here.
More about TerrAscend Corp
TerrAscend is a prominent cannabis company listed on the TSX, with operations spanning across North America, including states like Pennsylvania, New Jersey, Maryland, Michigan, Ohio, and California. The company is involved in vertically integrated operations, retail, cultivation, processing, and manufacturing, serving both medical and legal adult-use markets. It owns or licenses several brands such as Gage Cannabis, The Apothecarium, and Cookies.
Average Trading Volume: 339,341
Technical Sentiment Signal: Sell
Current Market Cap: C$127.7M
Find detailed analytics on TSND stock on TipRanks’ Stock Analysis page.